Kura Oncology
(KURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -197,667 | -123,551 | -57,429 | -173,983 | -154,766 |
| Depreciation Amortization | -6,477 | -4,717 | -2,421 | -12,293 | -9,612 |
| Accounts receivable | -33,876 | -2,514 | -46,686 | N/A | N/A |
| Other Working Capital | -3,355 | 12,502 | -20,052 | 286,173 | 3,915 |
| Other Operating Activity | 60,044 | 17,576 | 54,661 | 34,420 | 25,649 |
| Operating Cash Flow | $-181,331 | $-100,704 | $-71,927 | $134,317 | $-134,814 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 55,815 | -40,718 | -101,117 | -101,118 | -6,535 |
| PPE Investments | -4,317 | -1,750 | -292 | -472 | -100 |
| Investing Cash Flow | $51,498 | $-42,468 | $-101,409 | $-101,590 | $-6,635 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 658 | 658 | 143 | 154,417 | 153,611 |
| Financing Cash Flow | $658 | $658 | $143 | $154,417 | $153,611 |
| Beginning Cash Position | 224,462 | 224,462 | 224,462 | 37,318 | 37,318 |
| End Cash Position | 95,287 | 81,948 | 51,269 | 224,462 | 49,480 |
| Net Cash Flow | $-129,175 | $-142,514 | $-173,193 | $187,144 | $12,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -181,331 | -100,704 | -71,927 | 134,317 | -134,814 |
| Capital Expenditure | -4,317 | -1,750 | -292 | -472 | -100 |
| Free Cash Flow | -185,648 | -102,454 | -72,219 | 133,845 | -134,914 |